These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6116964)

  • 1. Lignocaine prophylaxis in acute myocardial infarction: an evaluation of randomised trials.
    DeSilva RA; Hennekens CH; Lown B; Casscells W
    Lancet; 1981 Oct; 2(8251):855-8. PubMed ID: 6116964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis of primary ventricular fibrillation in acute myocardial infarction. The case against lignocaine.
    Kertes P; Hunt D
    Br Heart J; 1984 Sep; 52(3):241-7. PubMed ID: 6380549
    [No Abstract]   [Full Text] [Related]  

  • 3. Restricted lignocaine prophylaxis in acute myocardial infarction.
    Löfmark R; Orinius E
    Acta Med Scand; 1977 Jan; 201(1-2):89-91. PubMed ID: 835377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lidocaine prophylaxis in acute myocardial infarction.
    Tisdale JE
    Henry Ford Hosp Med J; 1991; 39(3-4):217-25. PubMed ID: 1804827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Declining incidence of ventricular fibrillation in myocardial infarction. Implications for the prophylactic use of lidocaine.
    Antman EM; Berlin JA
    Circulation; 1992 Sep; 86(3):764-73. PubMed ID: 1516188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic lignocaine in hospitalized patients with acute myocardial infarction.
    O'Brien KP; Taylor PM; Croxson RS
    Med J Aust; 1973 Aug; 2(1):Suppl:36-7. PubMed ID: 4598559
    [No Abstract]   [Full Text] [Related]  

  • 7. Ventricular fibrillation complicating acute myocardial infarction: reasons against the routine use of lidocaine.
    Carruth JE; Silverman ME
    Am Heart J; 1982 Sep; 104(3):545-50. PubMed ID: 7113894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis of primary ventricular fibrillation with tocainide in acute myocardial infarction.
    Campbell RW; Hutton I; Elton RA; Goodfellow RM; Taylor E
    Br Heart J; 1983 Jun; 49(6):557-63. PubMed ID: 6405764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials.
    MacMahon S; Collins R; Peto R; Koster RW; Yusuf S
    JAMA; 1988 Oct; 260(13):1910-6. PubMed ID: 3047448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of primary ventricular fibrillation in acute myocardial infarction with prophylactic lidocaine.
    Wyman MG; Wyman RM; Cannom DS; Criley JM
    Am J Cardiol; 2004 Sep; 94(5):545-51. PubMed ID: 15342281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular tachyarrhythmias and lignocaine prophylaxis in acute myocardial infarction. A clinical and therapeutic study.
    Mogensen L
    Acta Med Scand Suppl; 1970; 513():1-80. PubMed ID: 5288550
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiarrhythmic prophylaxis after acute myocardial infarction. Is lidocaine still useful?
    Nattel S; Arenal A
    Drugs; 1993 Jan; 45(1):9-14. PubMed ID: 7680988
    [No Abstract]   [Full Text] [Related]  

  • 13. Lignocaine therapy for ventricular ectopic activity after acute myocardial infarction: a double-blind trial.
    Chopra MP; Thadani U; Portal RW; Aber CP
    Br Med J; 1971 Sep; 3(5776):668-70. PubMed ID: 4936439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lidocaine prophylaxis in acute myocardial infarction.
    Noneman JW; Rogers JF
    Medicine (Baltimore); 1978 Nov; 57(6):501-15. PubMed ID: 362121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How does lignocaine prevent ventricular fibrillation?
    Schapira AH
    Lancet; 1981 Nov; 2(8256):1167-8. PubMed ID: 6118602
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical pharmacokinetics of lignocaine.
    Benowitz NL; Meister W
    Clin Pharmacokinet; 1978; 3(3):177-201. PubMed ID: 350470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lignocaine prophylaxis for reperfusion arrhythmias during treatment with streptokinase in acute myocardial infarction.
    Ruano Marco M; Lacueva Moya V; Garcia Pardo J; Martin Montes N; Miquel Servet J; Rodriguez P
    Lancet; 1989 Oct; 2(8667):872-3. PubMed ID: 2571805
    [No Abstract]   [Full Text] [Related]  

  • 18. Reappraisal of lignocaine therapy in management of myocardial infarction.
    Pentecost BL; De Giovanni JV; Lamb P; Cadigan PJ; Evemy KL; Flint EJ
    Br Heart J; 1981 Jan; 45(1):42-7. PubMed ID: 7459164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients.
    Lie KI; Wellens HJ; van Capelle FJ; Durrer D
    N Engl J Med; 1974 Dec; 291(25):1324-6. PubMed ID: 4610392
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk-benefit stratification as a guide to lidocaine prophylaxis of primary ventricular fibrillation in acute myocardial infarction: an analytic review.
    Goldman L; Batsford WP
    Yale J Biol Med; 1979; 52(5):455-66. PubMed ID: 392960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.